Successful treatment of restless legs syndrome with the herbal prescription Yokukansan

Successful treatment of restless legs syndrome with the herbal prescription Yokukansan 1 <h5>Introduction</h5> The National Institutes of Health RLS workshop (2003) defined the diagnostic criteria. Essential criteria are: (1) an urge to move, accompanied with uncomfortable sensations in the legs; (2) the urge to move or unpleasant sensations begin or worsen during periods of rest or inactivity; (3) the urge to move or unpleasant sensations are relieved by movement; and (4) these symptoms are worse in the evening or night than during the day or occur only in the evening or night. Most RLS patients report difficulties falling asleep ( Montplaisir et al., 2005 ). It is also difficult to maintain their sleep because they awaken with unpleasant leg sensations ( Allen and Earley, 2001 ). As a consequence of frequent arousals from nocturnal sleep, patients often experience excessive daytime fatigue and somnolence. Several double-blind, placebo-controlled studies have demonstrated the superiority of pramipexole, an agonist for dopamine D2/D3 receptor, for the broad range of RLS symptoms ( Partinen et al., 2006 ). Clonazepam is prescribed to improve sleep continuity, because dopaminergic agents sometimes worsen insomnia and induce nausea. Yokukansan (YKS) was developed as a remedy for restlessness and agitation. In Japan, YKS prescription has been approved for patients with http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Progress in Neuro-Psychopharmacology & Biological Psychiatry Elsevier

Successful treatment of restless legs syndrome with the herbal prescription Yokukansan

Loading next page...
 
/lp/elsevier/successful-treatment-of-restless-legs-syndrome-with-the-herbal-tIA5ur7GMK
Publisher
Elsevier
Copyright
Copyright © 2009 Elsevier Inc.
ISSN
0278-5846
eISSN
1878-4216
D.O.I.
10.1016/j.pnpbp.2009.11.007
Publisher site
See Article on Publisher Site

Abstract

1 <h5>Introduction</h5> The National Institutes of Health RLS workshop (2003) defined the diagnostic criteria. Essential criteria are: (1) an urge to move, accompanied with uncomfortable sensations in the legs; (2) the urge to move or unpleasant sensations begin or worsen during periods of rest or inactivity; (3) the urge to move or unpleasant sensations are relieved by movement; and (4) these symptoms are worse in the evening or night than during the day or occur only in the evening or night. Most RLS patients report difficulties falling asleep ( Montplaisir et al., 2005 ). It is also difficult to maintain their sleep because they awaken with unpleasant leg sensations ( Allen and Earley, 2001 ). As a consequence of frequent arousals from nocturnal sleep, patients often experience excessive daytime fatigue and somnolence. Several double-blind, placebo-controlled studies have demonstrated the superiority of pramipexole, an agonist for dopamine D2/D3 receptor, for the broad range of RLS symptoms ( Partinen et al., 2006 ). Clonazepam is prescribed to improve sleep continuity, because dopaminergic agents sometimes worsen insomnia and induce nausea. Yokukansan (YKS) was developed as a remedy for restlessness and agitation. In Japan, YKS prescription has been approved for patients with

Journal

Progress in Neuro-Psychopharmacology & Biological PsychiatryElsevier

Published: Feb 1, 2010

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial